Methicillin resistance in Staphylococcus aureus infections among patients colonized with methicillin-susceptible Staphylococcus aureus.
Adult
Aged
Carrier State
/ microbiology
Cross Infection
/ microbiology
Female
Hospitalization
Humans
Male
Methicillin Resistance
/ genetics
Methicillin-Resistant Staphylococcus aureus
/ genetics
Middle Aged
Nasal Cavity
/ microbiology
Nose
/ microbiology
Odds Ratio
Ohio
Risk Factors
Staphylococcal Infections
/ microbiology
Staphylococcus aureus
/ drug effects
MRSA
MSSA
Staphylococcus aureus
Staphylococcus aureus carrier
Staphylococcus aureus colonization
Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
22
11
2017
revised:
13
03
2018
accepted:
31
03
2018
pubmed:
13
4
2018
medline:
26
4
2019
entrez:
13
4
2018
Statut:
ppublish
Résumé
We have noticed that patients colonized with methicillin-susceptible Staphylococcus aureus (MSSA) rarely get methicillin-resistant S. aureus (MRSA) infections. The purpose of this study was to compare the odds of a Staphylococcus aureus (SA) infection being an MRSA infection in MSSA carriers, MRSA carriers and non-carriers of SA. Hospitalizations of adult patients at the Cleveland Clinic Health System from 2008 to 2015 were screened to identify those where the patient was tested for SA colonization. The first such hospitalization was identified. Among these 90 891 patients, those who had an SA infection during the hospitalization were included. SA carrier status (MRSA, MSSA, or non-carrier), was defined based on the first nasal SA test result. The association of carrier status and MRSA infection was examined. The mean (±standard deviation (SD)) age of the 1999 included patients was 61 (17) years, and 1160 (58%) were male. Thirty percent, 26%, and 44%, were MRSA carriers, MSSA carriers and non-carriers, respectively. Of the 601 SA infections in MRSA carriers (reference group), 552 (92%) were MRSA infections compared with 42 (8%) of 516 in MSSA carriers (odds ratio (OR) 0.008, 95% confidence interval (CI) 0.005-0.012, p <0.0001) and 430 (49%) of 882 in non-carriers (OR 0.072, 95% CI 0.051-0.100, p <0.0001), after controlling for age, sex, hospital length of stay and calendar year. Among patients with SA infection, the odds of the infection being an MRSA infection are 125-times lower in an MSSA carrier than in an MRSA carrier.
Identifiants
pubmed: 29649598
pii: S1198-743X(18)30323-9
doi: 10.1016/j.cmi.2018.03.045
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
71-75Informations de copyright
Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.